Indications and uses
temporarily relieves minor aches and pains due to: • headache • minor arthritis pain • muscular aches • a cold toothache menstrual cramps • temporarily reduces fever
temporarily relieves minor aches and pains due to: • headache • minor arthritis pain • muscular aches • a cold toothache menstrual cramps • temporarily reduces fever
do not take more than directed (see overdose warning) adults and children 12 years of age and over: Open 1 pack, place powder on tongue every 6 hours, while symptoms persist. Drink a full glass of water with each dose, or may stir powder into a glass of water or other liquid. do not take more than 4 packs in 24 hours unless directed by a doctor. children under 12 years of age: ask a doctor.
Drug Facts
(in each caplet)
Acetaminophen 325 mg
Aspirin (NSAID*) 500 mg
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Aspirin may cause a severe allergic reaction which may include:
Acetaminophen may cause severe skin reactions. Symptoms may include: ▪ skin reddening
▪ blisters ▪ rash. If a skin reaction occurs, stop use and seek medical help right away.
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
These could be signs of a serious condition.
ask a health professional before use. It is especially important not to use aspirin at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Taking more than the recommended dose can cause serious health problems. In case of overdose, get medical help or contact Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.
lactose monohydrate, potassium chloride
1-866-255-5197
Goody’s BACK & BODY PAIN
Acetaminophen
Aspirin (NSAID)
Pain Reliever
Fever Reducer
24 POWDERS
Goody’s BACK & BODY PAIN
Acetaminophen
Aspirin (NSAID)
Pain Reliever
Fever Reducer
72 POWDERS
| Class | Version | Type | Effective |
|---|---|---|---|
| ASPIRIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Data Matrix | 289 | goodys-back-and-body-pain-02.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63029-600-01 | 2020-04-08 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-01 | 2020-04-08 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-06 | 2020-04-08 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-06 | 2020-04-08 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| 63029-600-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-281b-f424-e053-dadaa90a57ce | Goodys Back and Body Pain |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-600-01 | Goodys Back and Body Pain | 24 in 1 BOX | POWDER | 24 | 7 | |
| 63029-600-06 | Goodys Back and Body Pain | 6 in 1 BOX | POWDER | 6 | 7 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63029-600-01 | EA - Each | 63029-600 | 6319883d-3183-4ff1-9303-a0c2b2f79370 | 1 | 2022-06-06 |
| 63029-600-06 | EA - Each | 63029-600 | 037bf183-ff1a-44b2-af06-95a2c6e4b57c | 1 | 2022-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | 2 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | 2 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | 2 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 2 | |
| POTASSIUM CHLORIDE | INACTIVE INGREDIENT | 660YQ98I10 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63029-600 | 63029-600-01, 63029-600-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2024-10-25 | full-release | 2026-06-01 00:31:48 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | SUSPENSION / ORAL | NA | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | TABLET / ORAL | 231 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | SUSPENSION / ORAL | NA | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | TABLET / ORAL | 231 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | SUSPENSION / ORAL | NA | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / RESPIRATORY (INHALATION) | 0.18 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE / ORAL | 62 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE / ORAL | 62 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | TABLET / ORAL | 231 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / RESPIRATORY (INHALATION) | 0.18 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / NASAL | NA | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | 50 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / RESPIRATORY (INHALATION) | 0.18 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / NASAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | 50 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE / ORAL | 62 mg | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / NASAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | 50 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Goodys Back and Body Pain | ACETAMINOPHEN AND ASPRIN | Medtech Products Inc. | 055d0288-61d4-48bc-b91f-6ecc1969beb8 | 2025-10-23 | Warnings | 63029-600-01 63029-600-06 63029-600 63029060001 63029060006 8ec77abf-03a1-4692-959a-0bd779ecdc6c 055d0288-61d4-48bc-b91f-6ecc1969beb8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.